tetraethylammonium has been researched along with mepivacaine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedoya, M; Decher, N; González, W; Kiper, AK; Ramírez, D; Rinné, S | 1 |
| Bischoff, U; Bräu, ME; Hempelmann, G; Olschewski, A; Vogel, W | 1 |
1 review(s) available for tetraethylammonium and mepivacaine
| Article | Year |
|---|---|
TASK Channels Pharmacology: New Challenges in Drug Design.
Topics: Animals; Drug Design; Drug Discovery; Humans; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Tandem Pore Domain | 2019 |
1 other study(ies) available for tetraethylammonium and mepivacaine
| Article | Year |
|---|---|
Local anaesthetics block hyperpolarization-activated inward current in rat small dorsal root ganglion neurones.
Topics: Anesthetics, Local; Animals; Bupivacaine; Cyclic Nucleotide-Gated Cation Channels; Dose-Response Relationship, Drug; Electrophysiology; Ganglia, Spinal; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Inhibitory Concentration 50; Ion Channels; Lidocaine; Mepivacaine; Neurons; Potassium Channels; Pyrimidines; Rats; Tetraethylammonium; Time Factors | 2003 |